CALEY ALLEN: Open Payments
NPI 1821619362 · COCHRAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,989 in 139 payments from 42 companies in 2025. Trend: 2023 $1,965 · 2024 $2,131 · 2025 $2,989
Food & beverage: $2,973Education: $16
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 23 | $421 |
| AstraZeneca Pharmaceuticals LP | 13 | $358 |
| Merck Sharp & Dohme LLC | 13 | $292 |
| Daiichi Sankyo Inc. | 10 | $258 |
| BeOne Medicines USA, Inc. | 5 | $121 |
| Regeneron Healthcare Solutions, Inc. | 6 | $113 |
| Dendreon Pharmaceuticals LLC | 4 | $104 |
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| Genentech USA, Inc. | 4 | $85 |
| Astellas Pharma US Inc | 4 | $85 |
Products named: LYNPARZA, KEYTRUDA, IBRANCE, Enhertu, LIBTAYO, PROVENGE, Vyloy, ELREXFIO.
Industry payments across GA — which companies pay providers there.
